In Vivo Studies on the Influence of Bacteriophage Preparations on the Autoimmune Inflammatory Process

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Miȩdzybrodzki, Ryszard ^a,b   Borysowski, Jan ^b   Kłak, Marlena ^a   Jończyk Matysiak, Ewa ^a,c   Obmińska Mrukowicz, Bozena ^d   Suszko Pawłowska, Agnieszka ^d   Bubak, Barbara ^a   Weber Dabrowska, Beata ^a   Górski, Andrzej ^a,b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Regional Specialized Hospital   (Poland)

^d WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BODY WEIGHT; CELL POPULATION; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTERIA PHAGE T4; ENTEROCOCCAL PHAGE; FEMALE; IN VIVO STUDY; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PHAGE THERAPY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE; SPLEEN CELL; STAPHYLOCOCCUS PHAGE; SYSTEMIC THERAPY; THYMOCYTE; ANIMAL; AUTOIMMUNE DISEASE; COMPLICATION; DISEASE MODEL; ESCHERICHIA COLI; EXPERIMENTAL ARTHRITIS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; PATHOGENICITY; PROCEDURES; VIROLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; BACTERIOPHAGE T4; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; HUMANS; IMMUNOMODULATION; MICE; PHAGE THERAPY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGES; STAPHYLOCOCCUS PHAGES;

EID: 85037609269     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/3612015     Document Type: Article

References (19)

1. R. Midzybrodzki, J. Borysowski, B. Weber-Dbrowska, et al., "Clinical aspects of phage therapy, " Advances in Virus Research, vol. 83, pp. 73-121, 2012.
2. K. Kingwell, "Bacteriophage therapies re-enter clinical trials, " Nature Reviews Drug Discovery, vol. 14, no. 8, pp. 515-516, 2015.
3. C. Sansom, "Phage therapy for severe infections tested in the firstmulticentre trial, " The Lancet. Infectious diseases, vol. 15, no. 12, pp. 1384-1385, 2015.
4. E. Kutter, J. Borysowski, R. Midzybrodzki, et al., "Clinical phage therapy, " in Phage Therapy: Current Research and Applications, J. Borysowski, R. Midzybrodzki, A. Górski, Eds., pp. 257-288, Caister Academic Press, Norfolk, UK, 2014.
5. A. Górski, R. Midzybrodzki, J. Borysowski, et al., "Phage as a modulator of immune responses: Practical implications for phage therapy, " Advances in Virus Research, vol. 83, pp. 41-71, 2012.
6. J. H. Dean, J. S. Silva, J. L. McCoy, et al., "In vitro human reactivity to staphylococcal phage lysate, " The Journal of Immunology, vol. 115, no. 4, pp. 1060-1064, 1975.
7. L. K. Myers, E. F. Rosloniec, M. A. Cremer, A. H. Kang, "Minireview: Collagen-induced arthritis, an animal model of autoimmunity, " Life Sciences, vol. 61, no. 19, pp. 1861-1878, 1997.
8. R. Midzybrodzki, K. Switala-Jelén, W. Fortuna, et al., "Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes, " Virus Research, vol. 131, no. 2, pp. 233-242, 2008.
9. J. Boratynski, D. Syper, B. Weber-Dabrowska, M. usiak-Szelachowska, G. Pózniak, A. Górski, "Preparation of endotoxin-free bacteriophages, " Cellular and Molecular Biology Letters, vol. 9, no. 2, pp. 253-259, 2004.
10. S. Slopek, I. Durlakowa, B. Weber-Dabrowska, A. Kucharewicz-Krukowska, M. Dbrowski, R. Bisikiewicz, "Results of bacteriophage treatment of suppurative bacterial infections. I. general evaluation of the results, " Archivum Immunologiae et Therapiae Experimentalis, vol. 31, no. 3, pp. 267-291, 1983.
11. M. H. Adams, Bacteriophages, Interscience Publishers Inc, New York, NY, USA, 1959.
12. E. F. Rosloniec, M. Cremer, A. Kang, L. K. Myers, "Collagen-induced arthritis, " in Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, S. W. Shevach, Eds., pp. 15. 5. 1-15. 5. 19, Wiley, New York, NY, USA, 1996.
13. P. H. Wooley, "Collagen-induced arthritis in the mouse, " Methods in Enzymology, vol. 162, no. C, pp. 361-373, 1988.
14. A. Suszko and B. Obmínska-Mrukowicz, "Influence of polysaccharide fractions isolated fromCaltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate, " Journal of Ethnopharmacology, vol. 145, no. 1, pp. 109-117, 2013.
15. R. G. Caccese, J. L. Zimmerman, R. P. Carlson, "Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice, "Mediators of Inflammation, vol. 1, no. 4, pp. 273-279, 1992.
16. S. Yoshino, E. Sasatomi, Y. Mori, M. Sagai, "Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice, "The Journal of Immunology, vol. 163, no. 6, pp. 3417-3422, 1999.
17. M. usiak-Szelachowska, M. Zaczek, B. Weber-Dbrowska, "Phage neutralization by sera of patients receiving phage therapy, " Viral Immunology, vol. 27, no. 6, pp. 1-10, 2014.
18. A. Górski M. Kniotek, A. Perkowska-Ptasínska, et al., "Bacteriophages and transplantation tolerance, " Transplantation Proceedings, vol. 38, no. 1, pp. 331-333, 2006.
19. P. Miernikiewicz, A. Klopot, R. Soluch, et al., "T4 phage tail Adhesin Gp12 counteracts LPS-induced inflammation in vivo, " Frontiers in Microbiology, vol. 7, article no. 1112, 2016.